US2004018232A1PendingUtilityA1

Use of effect pigments in ingested drugs products

48
Assignee: ENGELHARD CORPPriority: Jun 26, 2001Filed: Jul 21, 2003Published: Jan 29, 2004
Est. expiryJun 26, 2021(expired)· nominal 20-yr term from priority
Inventors:Gabriel UzunianWilliam J. Sullivan
A61P 29/00A23G 3/362A23G 3/0097A61K 9/2813A61P 3/02A61K 9/2009A61K 47/02
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Ingestible drugs contain an effect pigment.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A composition comprising a ingestible drug in admixture with or coated with a platy effect pigment.  
     
     
         2 . A composition according to  claim 1  wherein the platy effect pigment is a platy titanium dioxide pigment, platy iron oxide pigment, platy bismuth oxychloride pigment, platy guanine pigment, or a combination thereof.  
     
     
         3 . A composition according to  claim 2  wherein the amount of platy effect pigment is about 1 weight percent or less of the composition.  
     
     
         4 . A composition according to  claim 3  wherein the ingestible drug is a pharmaceutical.  
     
     
         5 . A composition according to  claim 3  wherein the ingestible drug is a vitamin.  
     
     
         6 . A composition according to  claim 3  wherein the pigment is in a coating on the surface of the ingestible drug.  
     
     
         7 . A composition according to  claim 3  wherein the pigment is in admixture with the ingestible drug.  
     
     
         8 . A composition according to  claim 3  wherein the pigment is platy titanium dioxide.  
     
     
         9 . A composition according to  claim 2  wherein the ingestible product is a pharmaceutical.  
     
     
         10 . A composition according to  claim 2  wherein the ingestible drug is a vitamin.  
     
     
         11 . A composition according to  claim 2  wherein the pigment is in a coating on the surface of the ingestible drug.  
     
     
         12 . A composition according to  claim 2  wherein the pigment is in admixture with the ingestible drug.  
     
     
         13 . A composition according to  claim 2  wherein the pigment is platy titanium dioxide.  
     
     
         14 . A composition according to  claim 1  wherein the ingestible drug is a pharmaceutical.  
     
     
         15 . A composition according to  claim 1  wherein the ingestible drug is a vitamin.  
     
     
         16 . A composition according to  claim 1  wherein the pigment is in a coating on the surface of the ingestible drug.  
     
     
         17 . A composition according to  claim 1  wherein the pigment is in admixture with the ingestible drug.  
     
     
         18 . A composition according to  claim 1  wherein the pigment is platy titanium dioxide.  
     
     
         19 . A composition according to  claim 18  wherein the ingestible drug is a pharmaceutical.  
     
     
         20 . A composition according to  claim 18  wherein the ingestible drug is a vitamin.

Join the waitlist — get patent alerts

Track US2004018232A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.